Uptake of meningococcal conjugate vaccine among adolescents in large managed care organizations, United States, 2005: Demand, supply and seasonality

BACKGROUND: In February 2005, the US Advisory Committee on Immunization Practices recommended the new meningococcal conjugate vaccine (MCV4) for routine use among 11- to 12-year-olds (at the preadolescent health-care visit), 14- to 15-year-olds (before high-school entry), and groups at increased ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorick, Suchita A, Fishbein, Daniel, Weintraub, Eric, Wortley, Pascale M, Lee, Grace M, Zhou, Fangjun, Davis, Robert
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781813/
https://www.ncbi.nlm.nih.gov/pubmed/19887009
http://dx.doi.org/10.1186/1471-2334-9-175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781813/
https://www.ncbi.nlm.nih.gov/pubmed/19887009
http://dx.doi.org/10.1186/1471-2334-9-175

Ejemplares similares